Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Acorda Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −14 vs. Q1 2023
- Shares held
- 149.4K
- −85.6K (−36.4%) vs. Q1 2023Converted for a 1-for-20 split
- Total value
- $1.94M
- −$757.1K (−28.1%) vs. Q1 2023
- New holders
- 1
- 6 more added
- Sold out
- 15
- 3 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 2 | $8.00K |
| Q1 2024 | 17 | $2.13M |
| Q4 2023 | 15 | $2.33M |
| Q3 2023 | 16 | $2.30M |
| Q2 2023 | 15 | $1.94M |
| Q1 2023 | 30 | $3.71M |
| Q4 2022 | 36 | $4.09M |
| Q3 2022 | 36 | $1.91M |
| Q2 2022 | 35 | $3.08M |
| Q1 2022 | 34 | $5.42M |
| Q4 2021 | 34 | $9.48M |
| Q3 2021 | 36 | $14.7M |
| Q2 2021 | 37 | $18.1M |
| Q1 2021 | 37 | $18.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Acorda Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 1 | $13 | 0.00% | +0+81.8% | AddedConverted for a 1-for-20 split |
| Advisor Group Holdings, Inc. | 1 | $13 | 0.00% | +1+1,900.0% | AddedConverted for a 1-for-20 split |
| FMR LLC | 1 | $13 | 0.00% | +1 | New |
| First Manhattan Co | 3 | $39 | 0.00% | +1+20.0% | AddedConverted for a 1-for-20 split |
| Tower Research Capital LLC (TRC) | 8 | $104 | 0.00% | −585−98.7% | ReducedConverted for a 1-for-20 split |
| Group One Trading, L.P. | 204 | $2.65K | 0.00% | −124−37.8% | ReducedConverted for a 1-for-20 split |
| Russell Investments Group, Ltd. | 300 | $3.90K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Royal Bank of Canada | 516 | $7.00K | 0.00% | +500+3,036.8% | AddedConverted for a 1-for-20 split |
| Morgan Stanley | 1,276 | $16.6K | 0.00% | +797+166.5% | AddedConverted for a 1-for-20 split |
| Deutsche Bank AG | 1,700 | $22.1K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Wells Fargo & Company | 3,740 | $48.7K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| BlackRock Inc. | 6,776 | $88.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Acadian Asset Management LLC | 34,131 | $442.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Renaissance Technologies LLC | 45,561 | $593.0K | 0.00% | +1,296+2.9% | AddedConverted for a 1-for-20 split |
| Davidson Kempner Capital Management LP | 55,145 | $716.9K | 0.02% | −35,009−38.8% | ReducedConverted for a 1-for-20 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,942−100.0% | Sold outConverted for a 1-for-20 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −8,724−100.0% | Sold outConverted for a 1-for-20 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −7,989−100.0% | Sold outConverted for a 1-for-20 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −7,058−100.0% | Sold outConverted for a 1-for-20 split |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −3,835−100.0% | Sold outConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −3,335−100.0% | Sold outConverted for a 1-for-20 split |
| HN Saltoro Capital, LP | 0 | $0 | 0.00% | −2,570−100.0% | Sold outConverted for a 1-for-20 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,956−100.0% | Sold outConverted for a 1-for-20 split |
| State Street Corp | 0 | $0 | 0.00% | −1,582−100.0% | Sold outConverted for a 1-for-20 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −1,354−100.0% | Sold outConverted for a 1-for-20 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −771−100.0% | Sold outConverted for a 1-for-20 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −735−100.0% | Sold outConverted for a 1-for-20 split |
| Simon Quick Advisors, LLC | 0 | $0 | 0.00% | −719−100.0% | Sold outConverted for a 1-for-20 split |
| HRT Financial LP | 0 | $0 | 0.00% | −626−100.0% | Sold outConverted for a 1-for-20 split |
| UBS Group AG | 0 | $0 | 0.00% | −301−100.0% | Sold outConverted for a 1-for-20 split |
| Davidson Kempner Partners | – | – | – | – | Not filed |